Variant: rs612169 

    present in Gene: ABO
    present in Chromosome: 9
    Position on Chromosome: 133268030
    Alleles of this Variant: G/A

rs612169 in ABO gene and C-reactive protein measurement PMID 22291609 2012 A genome-wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation.

rs612169 in ABO gene and Corpuscular Hemoglobin Concentration Mean PMID 23222517 2012 Seventy-five genetic loci influencing the human red blood cell.

rs612169 in ABO gene and Glucose measurement PMID 21886157 2011 Human metabolic individuality in biomedical and pharmaceutical research.

rs612169 in ABO gene and Protein measurement PMID 23056639 2012 A genome-wide association study of circulating galectin-3.

rs612169 in ABO gene and Pseudocholinesterase Measurement PMID 21239051 2011 Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies.

rs612169 in ABO gene and Serum albumin measurement PMID 23281178 2013 A genome-wide assessment of variability in human serum metabolism.

rs612169 in ABO gene and Venous Thromboembolism PMID 21980494 2011 Genetics of venous thrombosis: insights from a new genome wide association study.

PMID 22672568 2012 A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q.

rs612169 in ABO gene and Venous Thrombosis PMID 22675575 2012 Caution in interpreting results from imputation analysis when linkage disequilibrium extends over a large distance: a case study on venous thrombosis.

rs612169 in ABO gene and elevated blood glucose level PMID 21886157 2011 Human metabolic individuality in biomedical and pharmaceutical research.

rs612169 in ABO gene and von Willebrand's factor (lab test) PMID 23381943 2013 Ischemic stroke is associated with the ABO locus: the EuroCLOT study.

PMID 28240269 2017 Connecting genetic risk to disease end points through the human blood plasma proteome.